Granite Creek Expands its Animal Health Portfolio with Veterinary Pharmaceutical Solutions’ Acquisition of Diamond Animal Health
08 Mayo 2024 - 10:01AM
Granite Creek Capital Partners, a Chicago-based private investment
firm, grows its footprint in the animal health market through its
recent funding of Veterinary Pharmaceutical Solutions’ (“VPS”)
acquisition of Diamond Animal Health (“Diamond”). Granite Creek
supported VPS’ acquisition of Diamond through a follow-on
investment from its FlexCap II fund, executing on the firm’s
continued pursuit of animal health investment opportunities.
Granite Creek purchased VPS, a licensed animal compounding
pharmacy focused on supporting the veterinary community in 2020,
and has actively supported the company in driving growth through
strategic investments in human capital, new product development,
and facility expansion. The Diamond acquisition represents the
first of many planned platform additions as the company looks to
expand its capabilities and market reach.
Granite Creek worked closely with VPS leadership through the
acquisition of Diamond, a contract manufacturer and researcher of
animal vaccines and pharmaceuticals that are utilized by
veterinarians of production and companion animals. The combined
business provides a full suite of solutions to meet veterinarians'
needs while remaining a valuable partner to other pharmaceutical
and biological companies working with Diamond to manufacture their
products. Furthermore, VPS and Diamond’s combined pharmacy,
chemistry, quality, and regulatory capabilities uniquely position
the company for rapid innovation.
“We view production animal health as an attractive end-market.
Innovative companies in this sector are critical in supporting
stable protein sources for consumers while ensuring efficiency and
safety in the supply chain,” said Mike Ray, Operating Partner at
Granite Creek Capital Partners. “The combination of VPS and Diamond
creates an integrated partner with the capabilities and capacity to
continue bringing innovative solutions to the market.”
“VPS’ acquisition of Diamond Animal Health is the first of many
planned platform additions as the company looks to expand its
capabilities and market reach, and it marks an exciting new chapter
for both VPS and Diamond,” said Dean Warras, Chief Executive
Officer of both entities. “We welcome Diamond Animal Health to our
team as we diversify our product offerings, expand our research,
further the company’s development capabilities, and elevate overall
operations.”
About Veterinary Pharmaceutical
SolutionsVeterinary Pharmaceutical Solutions (VPS) is a
Minnesota-based licensed pharmacy that provides animal health
products and services to the veterinary community. VPS has treated
over two billion pigs with compounded solutions that include
Water-Soluble Amoxicillin, Meloxicam, Ibuprofen, and more. VPS
creates custom medications tailored to the needs of an individual
animal or a small group of animals, all under the direct care of a
veterinarian. Founded in 1995, VPS has a rich legacy rooted in four
generations of family pharmacists who served their local community
for over a century.
To learn more about VPS, visit
www.veterinarypharmaceuticalsolutions.com.
About Diamond Animal Health Established in
1952, Diamond Animal Health is a leader in contract manufacturing
of animal pharmaceuticals and vaccines. Based in Des Moines, Iowa,
the company operates a USDA, FDA, and DEA-approved facility,
offering comprehensive services such as Research and Development,
Regulatory and Licensing Approvals, Contract Manufacturing, and
Logistics.
About Granite Creek Capital Partners,
L.L.C.Founded in 2005, Granite Creek Capital Partners,
L.L.C. is a Chicago-based private investment firm focused on
providing capital and operational resources to lower middle market
companies engaged in manufacturing, business services, healthcare,
and agribusiness. With an experienced team of investment
professionals bringing expertise in private equity, banking,
operations, and business development, Granite Creek has a
successful track record of investing in and supporting its
portfolio companies. In 2023, Granite Creek was named to Inc.’s
Founder-Friendly Investors list for the fourth year in a row,
honoring the private equity and venture capital firms with the best
track record of success backing entrepreneurs. For more information
on Granite Creek, visit www.granitecreek.com or call
312-895-4500.
For more media information, contact:Lisa Hendrickson, LCH
Communications for Granite
Creek516-643-1642lisa@lchcommunications.com